REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Gross profit, 2019
- $6.2B
- YoY, 2019
- +25.4%
- 5-year CAGR
- +18.0%
- 10-year CAGR
- +32.2%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2019 | $6.2B | +25.4% |
| 2018 | $4.9B | −13.4% |
| 2017 | $5.7B | +21.5% |
| 2016 | $4.7B | +20.8% |
| 2015 | $3.9B | +43.5% |
| 2014 | $2.7B | +35.4% |
| 2013 | $2.0B | +53.5% |
| 2012 | $1.3B | +193.1% |
| 2011 | $442M | −3.4% |
| 2010 | $457M | +21.0% |
| 2009 | $378M | +59.0% |
| 2008 | $238M | — |